Seed

Why the government’s haste in changing the health system could come back to haunt it

Retrieved on: 
Thursday, April 18, 2024

However, in the health sector this need for speed entails policy risks that could come back to bite the government before the next election.

Key Points: 
  • However, in the health sector this need for speed entails policy risks that could come back to bite the government before the next election.
  • The biggest such risk comes from the disestablishment of the Māori Health Authority-Te Aka Whai Ora.

More health sector confusion

  • While the parts of the act referring to the Māori Health Authority have been excised, the act retains its primary focus on reducing health inequities.
  • To date, health minister Shane Reti has avoided using the words “equity” or “inequities”, instead preferring a generic focus on improving health outcomes, including for Māori.
  • But the planning and decision making mandated under the legislation still require government health agencies to address health inequities.
  • Despite having misgivings about the re-centralisation of the health system, the government has not reversed the merging of 20 District Health Boards into Health New Zealand.

Health targets rebooted

  • Other changes resemble initiatives introduced during the last National-led government in 2009, including specific health targets.
  • The health targets involve specified performance levels, such as ensuring that 95% of patients visiting emergency departments are seen within six hours.
  • Health New Zealand bears either the cost of continuing to fund security guards or the reputational risk of their reduced presence.
  • The government may have already dented minister Reti’s chances of building positive relationships with health sector leaders and interest groups.
  • The Māori Health Authority had widespread support from health sector groups.
  • While governments often draw criticism from the health sector, few have done so quite this rapidly.


Tim Tenbensel receives funding from the Health Research Council. He is affiliated with Health Coalition Aotearoa.

Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1

Retrieved on: 
Thursday, April 18, 2024

REFERENCES ....................................................................................................................................... 14

Key Points: 
    • REFERENCES ....................................................................................................................................... 14

      29

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 3/14

      30

      EXECUTIVE SUMMARY

      31
      32
      33
      34
      35
      36

      This guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin

      37

      1.

    • Due to the inherent
      complexity of medicinal plants and herbal substances the quality of these starting materials requires an
      adequate quality assurance system for the collection and/or cultivation, harvest, and primary
      processing.
    • (either outdoor, indoor or in greenhouses) should be carefully considered, since each of the mentioned
      types could have several problems and advantages.
    • The used cultivation method may be dependent on
      the final application of the herbal medicinal product.
    • primary processing of herbal substances that are used for the preparation of herbal medicinal products.
    • medicinal plants and herbal substances, ensuring that they are handled appropriately throughout all
      stages of cultivation, collection, processing and storage.
    • their preparations are exposed to a large number of environmental contaminants of both biotic and
      abiotic origin.
    • to existing wildlife habitats and must adhere to CITES (Convention on International Trade in
      Endangered species of Wild Fauna and Flora).
    • https://health.ec.europa.eu/document/download/bd537ccf-9271-4230-bca1-2d...
      4 https://health.ec.europa.eu/document/download/fd318dd6-2404-4e67-82b0232...
      3

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 5/14

      104

      4.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 6/14

      147
      148
      149

      8.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 7/14

      185

      7.

    • Where possible, stable varieties and cultivars naturally
      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 8/14

      227
      228

      resistant or tolerant to disease should preferably be used.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 9/14

      268
      269
      270
      271
      272
      273

      The application should be carried out only by qualified staff using approved equipment.

    • The following should be noted:

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 10/14

      309
      310

      ?

      311
      312
      313

      ?

      314
      315
      316
      317

      ?

      318
      319
      320

      ?

      321
      322

      ?

      323
      324
      325

      ?

      326
      327
      328

      ?

      Damaged plants or plant parts need to be excluded or limited in accordance with a specific
      pharmacopoeia monograph, where relevant.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 11/14

      347
      348

      directly to the sun (except in cases where there is a specific need) and must be protected from
      rainfall, insect infestation, etc.

    • The label must be clear, permanently fixed and made from

      6

      Reflection paper on the use of fumigants (EMEA/HMPC/125562/2006)

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 12/14

      386
      387

      non-toxic material.

    • Certain exudates that have not been subjected to a specific treatment are

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 13/14

      425
      426
      427

      also considered to be herbal substances.

    • European Pharmacopoeia General Monograph ?HERBAL DRUGS? 07/2017:1433

      Are obtained by subjecting herbal substances to treatments such as
      extraction, distillation, expression, fractionation, purification, concentration
      or fermentation.

Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1

Retrieved on: 
Thursday, April 18, 2024

REFERENCES ....................................................................................................................................... 14

Key Points: 
    • REFERENCES ....................................................................................................................................... 14

      29

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 3/14

      30

      EXECUTIVE SUMMARY

      31
      32
      33
      34
      35
      36

      This guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin

      37

      1.

    • Due to the inherent
      complexity of medicinal plants and herbal substances the quality of these starting materials requires an
      adequate quality assurance system for the collection and/or cultivation, harvest, and primary
      processing.
    • (either outdoor, indoor or in greenhouses) should be carefully considered, since each of the mentioned
      types could have several problems and advantages.
    • The used cultivation method may be dependent on
      the final application of the herbal medicinal product.
    • primary processing of herbal substances that are used for the preparation of herbal medicinal products.
    • medicinal plants and herbal substances, ensuring that they are handled appropriately throughout all
      stages of cultivation, collection, processing and storage.
    • their preparations are exposed to a large number of environmental contaminants of both biotic and
      abiotic origin.
    • to existing wildlife habitats and must adhere to CITES (Convention on International Trade in
      Endangered species of Wild Fauna and Flora).
    • https://health.ec.europa.eu/document/download/bd537ccf-9271-4230-bca1-2d...
      4 https://health.ec.europa.eu/document/download/fd318dd6-2404-4e67-82b0232...
      3

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 5/14

      104

      4.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 6/14

      147
      148
      149

      8.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 7/14

      185

      7.

    • Where possible, stable varieties and cultivars naturally
      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 8/14

      227
      228

      resistant or tolerant to disease should preferably be used.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 9/14

      268
      269
      270
      271
      272
      273

      The application should be carried out only by qualified staff using approved equipment.

    • The following should be noted:

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 10/14

      309
      310

      ?

      311
      312
      313

      ?

      314
      315
      316
      317

      ?

      318
      319
      320

      ?

      321
      322

      ?

      323
      324
      325

      ?

      326
      327
      328

      ?

      Damaged plants or plant parts need to be excluded or limited in accordance with a specific
      pharmacopoeia monograph, where relevant.

    • Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 11/14

      347
      348

      directly to the sun (except in cases where there is a specific need) and must be protected from
      rainfall, insect infestation, etc.

    • The label must be clear, permanently fixed and made from

      6

      Reflection paper on the use of fumigants (EMEA/HMPC/125562/2006)

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 12/14

      386
      387

      non-toxic material.

    • Certain exudates that have not been subjected to a specific treatment are

      Guideline on Good Agricultural and Collection Practice (GACP) for starting materials of herbal origin
      EMA/HMPC/246816/2005

      Page 13/14

      425
      426
      427

      also considered to be herbal substances.

    • European Pharmacopoeia General Monograph ?HERBAL DRUGS? 07/2017:1433

      Are obtained by subjecting herbal substances to treatments such as
      extraction, distillation, expression, fractionation, purification, concentration
      or fermentation.

What did Roman wine taste like? Much better than previously thought, according to new research

Retrieved on: 
Wednesday, April 10, 2024

It is alleged that Roman winemakers had to mask their products’ flaws by adding spices, herbs and other ingredients to the freshly pressed grape juice, which is known as must.

Key Points: 
  • It is alleged that Roman winemakers had to mask their products’ flaws by adding spices, herbs and other ingredients to the freshly pressed grape juice, which is known as must.
  • Many of the longstanding misconceptions surrounding Roman wine come from a lack of insight into one of the most characteristic features of Roman winemaking: fermentation in clay jars or dolia.
  • In our research, we compared Roman dolia with traditional Georgian production vessels, called qvevri, which are still in use today.

Porous eggs buried in the ground

  • Unlike the metal or concrete containers used in modern winemaking, clay jars are porous, meaning the wine is exposed to air during fermentation.
  • The Romans used pitch from pine resin, while nowadays, in Georgia, neutral beeswax is applied.
  • By burying the vessels in the ground, winemakers can control temperature and provide a stable environment for wine to ferment and mature during its many months inside the jars.

Macerated wines

  • In clay jar winemaking, however, white wines regularly undergo long macerations with the grape solids (skins, seeds, and so on).
  • This wine – increasingly popular today – is similar to descriptions of some of the most prized wines in antiquity.

Protective yeast: the miracle of flor

  • Many of these are what we call “flor” yeasts, a thick white foam layer that protects the wine from contact with the air.
  • Flor produces several chemicals, including sotolon, which gives wine a spicy taste.

Roman wines revisited

  • By varying the size, shape and the position of dolia, Roman winemakers were able to have great control over the end product, as Georgian winemakers do today.
  • It not only debunks the alleged amateurish nature of Roman winemaking, but it also uncovers common traits in millennia-old winemaking techniques.


Dimitri Van Limbergen no recibe salario, ni ejerce labores de consultoría, ni posee acciones, ni recibe financiación de ninguna compañía u organización que pueda obtener beneficio de este artículo, y ha declarado carecer de vínculos relevantes más allá del cargo académico citado.

EQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply

Retrieved on: 
Wednesday, April 10, 2024

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply

Key Points: 
  • Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
    The issuer is solely responsible for the content of this announcement.
  • This important milestone guarantees a high level of patient safety and the long-term availability of the seeds within the EU.
  • Prostate seeds have been manufactured and internationally marketed by Eckert & Ziegler since 1999 and contribute several million euros in annual sales to the Eckert & Ziegler Group's earnings.
  • This is not only a significant achievement for the distribution of our brachytherapy products, but for the entire Eckert & Ziegler Group," explained Katrin Antonenko, Managing Director of Eckert & Ziegler BEBIG GmbH.

Syngenta Group reports $32.2 billion sales and $4.6 billion EBITDA in 2023

Retrieved on: 
Wednesday, April 10, 2024

Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.

Key Points: 
  • Full-year sales of Syngenta Crop Protection were 5 percent lower at $15.5 billion after exceptional growth in the previous year.
  • ADAMA sales decreased 17 percent to $5.6 billion for the full year 2023, with significant channel destocking, particularly in the Americas, affecting the comparison.
  • Syngenta Seeds sales grew 2 percent to $4.8 billion in the full year 2023 in an overall growing seeds market.
  • Sales of Syngenta Group China, consisting of the Group’s Seeds, Crop Protection, Crop Nutrition, MAP and digital activities in China, grew 11 percent to $9.6 billion in the full year 2023.

Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update

Retrieved on: 
Wednesday, March 13, 2024

Luxembourg, Mar 13, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023.

Key Points: 
  • Luxembourg, Mar 13, 2024 - (ACN Newswire) - Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023.
  • The main highlights of Moolec's business update are as follows:
    - SOOY1 | Piggy Sooy(TM) Platform: Third generation (T3) soybean seed propagation has started, and fourth generation (T4) seeds are expected to be harvested in April 2024.
  • - PEEA1: Scientific team confirms the presence of bovine myoglobin gene in pea seeds and the gene's stable inheritance across plant generations.
  • Thank you to the Moolers, and to our partners for their continued support," stated Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science.

Australian Oilseeds, Largest APAC Producer of Non-Chemical, Non- GMO “Cold-Processing” Vegetable Oil, Expands Australian Operations to the United States

Retrieved on: 
Tuesday, April 9, 2024

New York, NY and Sydney, Australia, April 09, 2024 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited (Nasdaq: COOT), a Cayman Islands exempted company “Australian Oilseeds” or “AOI”) is pleased to announce that it will be expanding its Australian operations to the United States effective July 2024. A pioneer in regenerative farming methods, AOI will, through its subsidiary company, Good Earth Oils, distribute Australian cold pressed NON-GMO canola oil and olive oil to retail and wholesalers in the United States.

Key Points: 
  • A pioneer in regenerative farming methods, AOI will, through its subsidiary company, Good Earth Oils , distribute Australian cold pressed NON-GMO canola oil and olive oil to retail and wholesalers in the United States.
  • AOI and Good Earth Oils purchase its NON-GMO canola seeds and olive oil from farmers who are reducing their use of chemicals in their farming systems.
  • Moreover they have an unwavering commitment to sustainability, investing in renewable energy (i.e., solar & biodiesel), and low impact packaging initiatives.
  • See more information at Australian Oilseeds website: www.australianoilseeds.au .

Chef Jason Triail of The Habit Burger Grill Given His Biggest Challenge Yet... By a Seven-Year-Old!

Retrieved on: 
Tuesday, April 9, 2024

IRVINE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Chef Jason Triail of The Habit Burger Grill faced an unexpected challenge of epic proportions—courtesy of a seven-year-old enthusiast!

Key Points: 
  • IRVINE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Chef Jason Triail of The Habit Burger Grill faced an unexpected challenge of epic proportions—courtesy of a seven-year-old enthusiast!
  • In a video message, Emmett challenged Chef Jason: "If you can make a Grown-Up Meal, can you make a grown-up gummy burger?"
  • Channeling his inner Willy Wonka, Chef Jason eagerly embraced the challenge, determined to bring Emmett's imaginative concept to life.
  • Guests at The Habit Burger Grill can always count on freshly made, handcrafted quality served up with genuine hospitality.

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

Retrieved on: 
Friday, April 5, 2024

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.